Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy

被引:0
|
作者
Nurbadriah binti Jasmiad
Rohana binti Abd Ghani
Renu Agarwal
Zaliha binti Ismail
Azlindarita Aisyah Mohd Abdullah
Mohd Yusri Idorus
机构
[1] Universiti Teknologi MARA (UiTM),Department of Internal Medicine, Faculty of Medicine
[2] Universiti Teknologi MARA (UiTM),Institute of Pathology, Laboratory and Forensic Medicine (I
[3] International Medical University,PPerForM)
[4] Universiti Teknology MARA (UiTM),Department of Pharmacology and Therapeutics, School of Medicine
[5] MSU Medical Centre,Department of Public Health Medicine, Faculty of Medicine
[6] MSU Clinical Centre of Excellence,Institute of Medical Molecular Biotechnology (IMMB), Faculty of Medicine
[7] Management and Science University,undefined
[8] Universiti Teknologi MARA (UiTM),undefined
来源
关键词
Type 2 diabetes mellitus; Diabetic retinopathy; Tissue plasminogen activator (tPA); Plasminogen activator inhibitor-1 (PAI-1);
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
    Jasmiad, Nurbadriah Binti
    Abd Ghani, Rohana Binti
    Agarwal, Renu
    Ismail, Zaliha Binti
    Abdullah, Azlindarita Aisyah Mohd
    Idorus, Mohd Yusri
    [J]. BMC OPHTHALMOLOGY, 2022, 22 (01)
  • [2] Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke
    Johansson, L
    Jansson, JH
    Boman, K
    Nilsson, TK
    Stegmayr, B
    Hallmans, G
    [J]. STROKE, 2000, 31 (01) : 26 - 32
  • [3] Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients
    Lindgren, A
    Lindoff, C
    Norrving, B
    Astedt, B
    Johansson, BB
    [J]. STROKE, 1996, 27 (06) : 1066 - 1071
  • [4] Plasminogen activator inhibitor-1 overexpression in nonproliferative diabetic retinopathy
    Grant, MB
    Ellis, EA
    Caballero, S
    Mames, RN
    [J]. EXPERIMENTAL EYE RESEARCH, 1996, 63 (03) : 233 - 244
  • [5] Plasminogen Activator Inhibitor-1 Overexpression in Nonproliferative Diabetic Retinopathy
    Grant, M. B.
    Ellis, E. A.
    Caballero, S.
    Mames, R. N.
    [J]. Experimental Eye Research, 63 (03):
  • [6] Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 levels in acute myocardial infarction
    Ganti, AK
    Potti, A
    Yegnanarayan, R
    [J]. PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2002, 32 (02) : 80 - 84
  • [7] Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Patients with Acute Paraquat Intoxication
    Seok, Su-Jin
    Kim, Su-Ji
    Gil, Hyo-Wook
    Yang, Jong-Oh
    Lee, Eun-Young
    Hong, Sae-Yong
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (04) : 474 - 481
  • [8] Tissue plasminogen activator and plasminogen activator inhibitor-1 promote tissue integration of biomaterial
    Hessenauer, M.
    Reichel, C. A.
    Berghaus, A.
    Strieth, S.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2013, 43 : 8 - 8
  • [9] Tissue plasminogen activator and plasminogen activator inhibitor-1 in human choledochal bile
    Lee, SJ
    Cho, JS
    Chung, JP
    Lee, KS
    Chung, JB
    Lee, SI
    Moon, YM
    Kang, JK
    Park, IS
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A19 - A19
  • [10] Effect of Tisseel® on expression of tissue plasminogen activator and plasminogen activator inhibitor-1
    Diamond, MP
    Kruger, M
    Saed, GM
    [J]. FERTILITY AND STERILITY, 2004, 81 (06) : 1657 - 1664